The role of TMPRSS2-Inhibitor Camostat in the pathogenesis of COVID-19 in lung cells“
Abstract
Stefan Bittmann*, Elena Moschüring Alieva, Anne Weissenstein, Elisabeth Luchter, Gloria Villalon Author Affiliations Department of Pediatrics, Ped Mind Institute (PMI), Germany Received: April 14, 2020 | Published: May 08, 2020 Corresponding author: Stefan Bittmann MD, MA, Head of the Department of Pediatrics and Ped Mind Institute (PMI), Pediatrician, Hindenburgring 4, D-48599 Gronau, Germany DOI: 10.26717/BJSTR.2020.27.004519
Metrics
Citation History
Topics
Related Documents
COVID 19: Camostat and The Role of Serine Protease Entry Inhibitor TMPRSS2
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
Jesper Damsgaard GunstNina Breinholt StærkeMarie H. PahusLena Hagelskjær KristensenJacob BodilsenNicolai LohseLars DalgaardDorthe BrønnumOle FröbertBo Langhoff HøngeIşık Somuncu JohansenIda MonradChristian ErikstrupRegitze RosendalEmil VilstrupTheis MariagerDorthe Gaby BovéRasmus OffersenShakil ShakarSara CajanderNis Pedersen JørgensenSajitha Sophia SritharanPeter BreiningS.K. JespersenKlaus Leth MortensenMads Langballe JensenLilian KolteGiacomo S. FrattariCarsten Schade LarsenMerete StorgaardLars Peter NielsenMartin TolstrupEva Aggerholm SædderLars ØstergaardHien T. T. NgoMorten Hasselstrøm JensenJesper Falkesgaard HøjenMads KjølbyOle S. Søgaard